Researchers at IRB Barcelona identify a possible therapeutic target for Kennedy´s disease and prostate cancer

08.08.2019

Activation of the chaperone protein Hsp70 leads to a decrease in the formation of androgen receptor aggregates, which give rise to muscular atrophy in patients with Kennedy´s disease, a rare condition for which no treatment is available.

The results may also be useful in the search for a treatment for castration-resistant prostate cancer, a disease that causes 30,000 death a year in Europe and for which there is no treatment.

The study, which has been published in Nature Communications, is a collaboration with the University of California San Francisco and the University of Michigan.